TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nigaard Pharma Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
72
|
36 | |
| Financial expenses | 1 | ||
| Earnings before taxes |
-253
|
19
|
-80 |
| Total assets |
99
|
72
|
38 |
| Current assets |
89
|
0
|
2 |
| Current liabilities |
22
|
38
|
116 |
| Equity capital |
77
|
36
|
-77 |
| - share capital |
3
|
3
|
3 |
| Employees (average) |
1
|
1 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
77.8%
|
50.0%
|
-202.6% |
| Turnover per employee | 72 | ||
| Profit as a percentage of turnover |
26.4%
|
-222.2% | |
| Return on assets (ROA) | 27.8% | ||
| Current ratio |
404.5%
|
0%
|
1.7% |
| Return on equity (ROE) |
-328.6%
|
52.8%
|
103.9% |
| Change turnover | 36 | ||
| Change turnover % | 100% | ||
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.